Back to Authors

He, Kai

https://orcid.org/0000-0001-9905-5906

A5100700364 | I2799885155

Mayo Clinic

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Citations 1

535 EVEREST-2: a phase 1/2 study of A2B694, a logic-gated Tmod CAR T therapy to treat solid tumors expressing mesothelin (MSLN) with HLA-A*02 loss of heterozygosity: initial safety and efficacy results

Regular and Young Investigator Award Abstracts | November 10, 2025 | Volume: No volume available | Issue: No issue available | Pages: A611-A612

10.1136/jitc-2025-sitc2025.0535